ARDT ardenthealth.com: Price-to-Projected Revenue Ratio

Corporate emblem and logo of Ardent Health Corp (ARDT)

Despite staffing shortages and nursing turnover, Ardent Health Partners, Inc. (ARDT) is actively recruiting IT talent. This chart of the company's expected P/S ratio visualizes market expectations, where 0.30 shows the current value of the metric. The implementation of AI in patient logistics optimizes the network's operations, while competent management ensures expense transparency and high operational efficiency for the recent IPO.

ARDT (Ardent Health) Price to Expected Revenue Ratio history from 11/23/2024 to 11/13/2026

Comprehensive metric breakdowns and analytics for Ardent Health Corp (ARDT)

- current price and projected stock value:
- company stock capitalization data:
Initial company analysis:Ardent Health Partners ARDT
Product sample of Ardent Health Corp

The forward P/S reflects the ratio of the company's market capitalization to projected revenue, allowing for an assessment of the value of each unit of expected sales. For Ardent Health Partners, Inc. (ARDT), this indicator demonstrates the scaling efficiency of hospital networks in major metropolitan areas. Analyzing the business's forward P/S helps identify asset overvaluation relative to the expansion rates of medical systems. The stability of this metric confirms the resilience of the investment profile when implementing unified management standards.

Competitors of Ardent Health Partners, Inc.

Forward P/S Multiple HCA (HCA Healthcare)|Tenet Healthcare Corp (THC) - Market Cap to Future Revenue Ratio|FMS - Price-to-Projected Revenue Ratio|SOLV (Solventum Health) - Market Cap to Projected Revenue|EHC (Encompass Health) - Forward Price-to-Revenue Multiple|UHS: Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple DVA|RDNT: Forward Price to Sales|Forward P/S Multiple OPCH|SGRY (Surgery Partners Group) - Forward Price to Sales|Forward P/S Multiple PINC (Premier, Inc.)|nationalvision.com (EYE) - Market Cap to Future Revenue Ratio|Progyny - Forward P/S Multiple|SEM - Forward P/S Multiple|Apollo Medical Holdings (ASTH) - Price-to-Projected Revenue Ratio|MD (MEDNAX) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple USPH|PNTG (pennantgroup.com) - Price to Expected Revenue Ratio|Forward P/S Multiple ORGO|NUTX (Nutex Health Inc) - Forward Price to Sales|Auna Health - Forward Price-to-Revenue Multiple|Forward Price to Sales SBC|EOLS - Price-to-Projected Revenue Ratio|Future Price to Revenue CYH|SKIN: Forward P/S Multiple|MediWound (MDWD) - Forward P/S Multiple|Price-to-Projected Revenue Ratio Biote Corp|JYNT: Forward Price to Sales|Forward Price-to-Revenue Multiple DCGO (DocGo Inc.)|Price to Expected Revenue Ratio PIII|Price-to-Projected Revenue Ratio Gain Therapeutics GANX|EUDA: Market Cap to Projected Revenue|Basel Medical Group Limited - Forward P/S Multiple|Market Cap to Future Revenue Ratio CollPlant Biotechnologies|Cuprina Holdings (Cayman) Ltd (CUPR) - Price-to-Projected Revenue Ratio|concordmedical.com - Forward Price to Sales|Price-to-Projected Revenue Ratio American Shared Hospital Services|MEDIROM Healthcare Group Inc. (MRM) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple ALBT (Avalon GloboCare)|DHAI (DIH Group) - Forward Price to Sales|Forward P/S Multiple XAGE (Longevity Health Holdings)|Market Cap to Expected Sales Ratio newgenivf.com (NIVF)|ATIP - Price-to-Projected Revenue Ratio|CMAX (CareMax Inc.) - Market Cap to Projected Revenue|KDLY: Forward P/S Multiple|Forward Price-to-Revenue Multiple ModivCare Corp|Forward Price-to-Revenue Multiple NVOS|SunLink Health Systems, Inc (SSY) - Market Cap to Expected Sales Ratio|Forward P/S Multiple BACK